Related Experiment Videos
Genetic and biochemical screening for endocrine disease: II. Ethical issues
1Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
World Journal of Surgery
|December 5, 1998
Summary
Genetic screening for disease susceptibility raises significant ethical concerns. Understanding these issues is crucial for developing regulations impacting patient care, law, and insurance.
Area of Science:
- Medical Ethics
- Genetics
- Public Health Policy
Background:
- Genetic testing for disease susceptibility is advancing rapidly.
- This advancement presents complex ethical challenges in patient care.
- Societal and regulatory frameworks are struggling to keep pace.
Purpose of the Study:
- To review the ethical implications of genetic screening.
- To examine the intersection of genetic screening with legal and insurance sectors.
- To inform the development of appropriate societal regulations.
Main Methods:
- Literature review of ethical, legal, and insurance aspects of genetic screening.
- Analysis of current regulatory and policy landscapes.
- Synthesis of ethical concerns and their practical implications.
Main Results:
- Genetic screening poses ethical dilemmas regarding patient autonomy and privacy.
- Legal and insurance frameworks are adapting, but gaps remain.
- A comprehensive understanding of ethical issues is vital for policy development.
Conclusions:
- Ethical considerations must guide the implementation of genetic screening.
- Interdisciplinary dialogue is needed to address legal and insurance challenges.
- Proactive ethical analysis is essential for responsible genetic medicine.
Keywords:
Genetics and Reproduction